Gimzo, Israel

Yehuda Schnaps

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Indamed. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yehuda Schnaps: Innovator in Arrhythmia Diagnosis

Introduction

Yehuda Schnaps is a notable inventor based in Gimzo, Israel. He has made significant contributions to the field of medical technology, particularly in the diagnosis of arrhythmias. His innovative approach combines wearable technology with advanced diagnostic methods to improve patient care.

Latest Patents

Yehuda Schnaps holds a patent for a "System and method for arrhythmia diagnosis." This patent outlines a comprehensive method for diagnosing arrhythmia focus in a patient's heart. The process involves affixing electrodes to the patient, utilizing a wearable monitor to capture ECG waveforms, and analyzing these waveforms to identify arrhythmia focus. This innovative method enhances the accuracy and efficiency of arrhythmia diagnosis.

Career Highlights

Throughout his career, Yehuda has focused on developing technologies that bridge the gap between patient monitoring and diagnostic accuracy. His work has been instrumental in advancing the capabilities of wearable medical devices. With a patent count of 1 patent, he continues to push the boundaries of medical innovation.

Collaborations

Yehuda has collaborated with notable professionals in the field, including Asher Shtekel and Chanan Schneider. These partnerships have contributed to the development and refinement of his innovative diagnostic methods.

Conclusion

Yehuda Schnaps is a pioneering inventor whose work in arrhythmia diagnosis exemplifies the intersection of technology and healthcare. His contributions are paving the way for more effective patient monitoring and diagnosis in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…